title: BAFF serum levels in myasthenia gravis: effects of therapy.
authors.forename: Flavia
authors.initials: F
authors.lastname: Scuderi
authors.forename: Paolo E
authors.initials: PE
authors.lastname: Alboini
authors.forename: Emanuela
authors.initials: E
authors.lastname: Bartoccioni
authors.forename: Amelia
authors.initials: A
authors.lastname: Evoli
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D053264:B-Cell Activating Factor / Q000097:blood*; D015415:Biomarkers / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D013934:Thymectomy; D055815:Young Adult
chemical_list: D053264:B-Cell Activating Factor; D015415:Biomarkers; D007166:Immunosuppressive Agents; C505719:TNFSF13B protein, human